Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (T14) under the Base Case is USD per share.
Compared with the current market price of 2.61 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Tianjin Pharmaceutical Da Ren Tang Group Does
Tianjin Pharmaceutical Da Ren Tang Group makes and sells traditional Chinese medicines, prescription drugs, over-the-counter remedies, and related health products. Its core business is turning classic Da Ren Tang formulas into branded medicines that are sold through pharmacies, hospitals, distributors, and direct retail channels. The company earns money by manufacturing these products and selling them under its own brand.
- Headquarters
- China CN
- Employees
- 3 890
- IPO date
- Jun 6, 2001
Revenue & Expenses Breakdown
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
What is the Intrinsic Value of one T14 stock?
The intrinsic value for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (T14) under the Base Case is USD.
Is T14 stock undervalued or overvalued?
Compared with the current market price of 2.61 USD, the stock appears .
